Search

BackgroundCorticosteroids are among the most frequently prescribed drugs in the world because they are extremely effective for the relief of symptoms of many inflammatory and immune disorders and other conditions. Corticosteroids have been a mainstay of pharmacotherapy in dermatological practice.ObjectiveThis study aimed to assess prescribing practices of corticosteroids in outpatient dermatology department of Injibara General Hospital, North-West Ethiopia, 2024.MethodA facility-based retrospective cross-sectional study was conducted from September 1 to September 10, 2024, with 422 patient prescriptions issued at the dermatology outpatient department of Injibara General Hospital containing at least one corticosteroid medicine. All patient prescriptions dispensed from the dermatology outpatient department from April to August 2024 containing at least one corticosteroid medicine were included. A structured data collection tool was used to collect data, and Statistical Package for Social Science version 27.1 was used for data analysis. The study population was characterized through descriptive analysis.ResultsFemale patients accounted 54.2% of the cases recorded, and the most common age group was between 21 and 30 years (26.5%). Atopic dermatitis (15.4%) was the most common skin disorder, followed by papular urticaria (9.97%) and seborrheic dermatitis (8.9%) for which corticosteroids were prescribed. Topical corticosteroids were the most commonly prescribed medications, accounting for 94.1%. The percentage of corticosteroids prescribed by generic name was 82.4%. We found that the percentage of topical corticosteroid prescriptions in fixed drug combinations and extemporaneous prescription was 4.4 and 1.2%, respectively. Mometasone furoate was the most commonly prescribed (34.6%), followed by clobetasol propionate (26.7%). Ointments (53%) followed by creams (40.6%) were the most common formulations of topical corticosteroids issued. In the present study, moderate potency TCS were most commonly prescribed (32.3%), followed by high potency (28.3%), and super high potency (27.6%), respectively.ConclusionFrom this study, it can be concluded that atopic dermatitis is the most common skin disease observed in the studied dermatology outpatient where the corticosteroid was indicated. Mometasone furoate and clobetasol propionate were the two most commonly prescribed agents. Prescribing practice of high potent and very high potent topical corticosteroids was found to be considerably high.

BackgroundIrrational use of medicines is a problem globally that soon needs to be addressed. According to estimates from the World Health Organization, almost half of all medications were improperly prescribed. This study aimed to assess the drug prescribing patterns based on World Health Organization drug use indicators in the dermatology outpatient department of Injibara General Hospital.MethodA facility-based retrospective cross-sectional study was conducted from August 15 to August 30, 2024, with 620 patient prescriptions issued at the dermatology outpatient department of Injibara General Hospital. All patient prescriptions dispensed from the dermatology outpatient department from April to July 2024 were included. A structured data collection tool adopted from the World Health Organization core medicine use indicator was used to collect data, and Statistical Package for Social Science version 27.1 was used for data analysis.ResultsAn average of 1.74 drugs per encounters was prescribed, with 21.6 and 3.1% of prescriptions being antibiotics and injections, respectively. Generics were used in 95.4% of prescriptions, and nearly 84% of drugs were prescribed from the Ethiopian essential-drug list.ConclusionThe World Health Organization’s recommended threshold for the average number of prescriptions prescribed per encounter was met, indicating proper prescribing practices that reduce polypharmacy. The percentage of encounters with antibiotics was within the World Health Organization’s value, which reflects that dermatologists are less likely engaging in irrational antibiotic prescriptions. Likewise, the World Health Organization’s recommendations for the percentage of encounters with injection was met, indicating an effort to minimize unnecessary use of injections by dermatologists, which can reduce complications associated with injection use. However, the World Health Organization’s guidelines for generic drug prescriptions were not met, suggesting that dermatologists are less likely to prescribe generic drugs, which can raise patient healthcare expenditures considerably. Prescriptions from the Ethiopian essential medicine list also fell short of World Health Organization’s standards, indicating a failure to follow established guidelines.

BackgroundDyslipidemia is a common condition in type two diabetic patients, and it is thought to have a significant role in moderating the cardiovascular risk associated with diabetes. Data on serum lipid profiles in type 2 diabetes patients from Bahir Dar, Ethiopia is limited. This study aimed to evaluate the prevalence of dyslipidemia among adult type 2 diabetes patients and to explore potential contributing factors.Method and materialsA facility-based cross-sectional study was conducted with 354 type 2 diabetes mellitus patients from April 3 to June 4, 2023. Data were collected through the use of structured questionnaires and checklists. The data were entered into EpiData version 4.6 and analyzed using SPSS version 26. Logistic regression was employed to identify variables significantly associated with the outcomes, with a p-value ≤ 0.05 and a 95% confidence interval.ResultsA total of 369 individuals with diabetes were approached in this study, resulting in a response rate of 96%. The overall prevalence of dyslipidemia was 61.3% (95% CI: 56.2–66.7). Of those with dyslipidemia, 11% had a single serum lipid abnormality, while 50.3% had a combined serum lipid abnormality. Significant factors associated with dyslipidemia included being over 60 years old (AOR: 2.4, 95% CI: 1.2–5.0), poor fasting blood glucose control (AOR: 2.5, 95% CI: 1.2–5.1), being overweight (AOR: 5.8, 95% CI: 3.2–11), physical inactivity (AOR: 3.4, 95% CI: 1.7–7.0), and being a past alcohol drinker (AOR: 3.1, 95% CI: 1.3–7.4).ConclusionIn the study area, a high prevalence of dyslipidemia was found among diabetic patients. Independent factors associated with dyslipidemia included older age, poor fasting blood glucose control, physical inactivity, a history of alcohol consumption, and being overweight. To address this issue, it is essential to implement preventive measures such as early detection, patient education, dietary monitoring, regular clinical visits, physical exercise, and weight management. These strategies represent the most effective approach to combating dyslipidemia.